# Jinghong Medical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/jinghong-medical

- Industry: Medical Devices & Equipment
- Headquarters: Shanghai, China
- Website: www.jinghongmedical.com
- Latest round: Series A (Dec 29, 2025)
- Investors on record: 1

## About

Based in Shanghai, China, Jinghong Medical specializes in innovative medical devices that enhance patient outcomes across various clinical settings, particularly in cardiology, orthopedics, and chronic disease management.Founded in 2021, Jinghong Medical Technology develops and distributes advanced medical devices. The firm has completed a total of 1 deal, with its most recent funding round occurring on December 29, 2025. The company's founder has a track record of establishing successful ventures in the healthcare sector.Jinghong Medical specializes in the development and distribution of innovative medical devices aimed at enhancing patient outcomes in various clinical settings. The company’s core product offerings include advanced diagnostic instruments and therapeutic devices that cater primarily to healthcare providers specializing in areas such as cardiology, orthopedics, and chronic disease management. These products are designed to improve the accuracy of diagnoses and the efficiency of treatments, addressing critical challenges faced by healthcare professionals in both hospital and outpatient environments. Jinghong Medical serves a diverse client base, including hospitals, clinics, and medical laboratories across specific international markets, such as Southeast Asia and parts of Europe. The focus on these geographical areas reflects the company's strategy to penetrate markets where the demand for high-quality medical technology is rapidly increasing.Jinghong Medical generates revenue through a structured B2B model, primarily engaging in direct sales to healthcare institutions and partnerships with distributors worldwide. The sales transactions typically involve bulk orders of their flagship diagnostic and therapeutic products, with pricing tiers based on volume and specific contract terms negotiated with individual clients. This transactional model allows for predictable revenue streams, as hospitals and clinics often establish ongoing supply agreements to ensure consistent access to essential medical devices. In addition to direct sales, the company may also explore subscription services for certain diagnostic technologies, providing clients with continuous access to the latest innovations and updates. The revenue framework emphasizes quality and reliability, ensuring that healthcare providers can depend on Jinghong Medical's offerings to meet their operational needs efficiently.On December 29, 2025, Jinghong Medical raised an undisclosed amount in a Series A funding round co-led by Wuxi Yuanyue Private Equity Fund Management and Jinkong Qiyuan Capital, with participation from Digital Industry Venture Capital and Xiaoya Capital. The company plans to utilize the recent funding to develop and launch new products designed to address specific healthcare needs. Additionally, Jinghong Medical intends to expand into Southeast Asian markets and parts of Europe by 2026, capitalizing on the increasing demand for advanced medical technologies in these regions.

## Funding rounds

- Series A, Dec 29, 2025 — Wuxi Yuanyue Private Equity Fund Management

## Investors

- Wuxi Yuanyue Private Equity Fund Management (https://capitalatlas.ai/funds/wuxi-yuanyue-private-equity-fund-management) — Series A